Related Experiment Video
Updated: Feb 9, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Type 1 Diabetes Mellitus in Saudi Arabia: A Soaring Epidemic
Asirvatham Alwin Robert1, Abdulrahman Al-Dawish2, Muhammad Mujammami3
1Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Insights
Type 1 diabetes mellitus (T1DM) is rising globally, especially in young children. This review examines T1DM in Saudi Arabia, highlighting a lack of research despite high incidence rates.
Area of Science:
- Endocrinology
- Pediatrics
- Public Health
Background:
- Type 1 diabetes mellitus (T1DM) affects 1 in 300 people globally, with incidence increasing by 3% annually.
- Alarmingly, T1DM is increasingly diagnosed in infants as young as six months.
- This necessitates tailored management strategies for young children with T1DM.
Purpose of the Study:
- To review the current literature on Type 1 diabetes mellitus in Saudi Arabia.
- To highlight the prevalence, incidence, and sociodemographic aspects of T1DM in the Saudi population.
- To identify research gaps in T1DM management for children in Saudi Arabia.
Main Methods:
- Literature review of published studies on T1DM in Saudi Arabia.
- Analysis of data from the Diabetes Atlas (8th edition).
- Synthesis of information on prevalence, incidence, and sociodemographic factors.
Main Results:
- Saudi Arabia has 35,000 children and adolescents with T1DM.
- The country ranks 8th globally in the number of T1DM patients and 4th in incidence rate (33.5 per 100,000).
- There is a significant lack of research on T1DM in Saudi Arabia compared to developed nations.
Conclusions:
- T1DM poses a significant challenge in Saudi Arabia, particularly for the pediatric population.
- Urgent need for increased research on T1DM prevalence, incidence, and management in Saudi Arabia.
- Further studies are crucial to develop effective T1DM management systems for children in the region.
Abstract:
Type 1 diabetes mellitus (T1DM) is quite prevalent in the world, with a proportion of 1 in every 300 persons and steadily rising frequency of incidence of about 3% every year. More alarmingly, the incidence of T1DM among infants is also increasing, with children as young as 6 months succumbing to it, instead of that at a rather established vulnerable age of around seven and near puberty, when the hormones antagonize the action of insulin. These reports pose a unique challenge of developing efficient T1DM management system for the young children. The Kingdom of Saudi Arabia (KSA) is the largest country in the Middle East that occupies approximately four-fifths of the Arabian Peninsula supporting a population of more than 33.3 million people, of whom 26% are under the age of 14 years. As per the Diabetes Atlas (8th edition), 35,000 children and adolescents in Saudi Arabia suffer from T1DM, which makes Saudi Arabia rank the 8th in terms of numbers of TIDM patients and 4th country in the world in terms of the incidence rate (33.5 per 100,000 individuals) of TIDM. However, in comparison with that in the developed countries, the number of research interventions on the prevalence, incidence, and the sociodemographic aspects of T1DM is woefully inadequate. In this review we discuss different aspects of T1DM in Saudi Arabia drawing on the published literature currently available.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications

